Pre-Clinical News
-
Tris Pharma Partners with Perigon Pharmacy 360 to Enhance Access to DYANAVEL® XR Tablets for the Treatment of Attention Deficit Hyperactivity Disorder
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced a new partnership with Perigon Pharmacy 360, a full-service, specialty digital pharmacy, to enhance accessibility, affordability and adherence for patients treating symptoms of ADHD with Tris’ ...
-
Innovative SILAC-Based Proteomics Analysis Service Launched by Creative Proteomics
Creative Proteomics, a respected leader in the field of proteomics services, has unveiled its latest offering: the cutting-edge SILAC-Based Proteomics Analysis Service. This advanced service promises to enhance protein dynamics analysis and quantification with a focus on precision and reliability, catering to the research community's evolving needs. SILAC, or Stable Isotope Labeling by Amino ...
-
Amerigo Scientific Rolls Out Real-Time PCR Kits to Facilitate HAV Research
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, recently rolled out their cutting-edge real-time PCR kits for Hepatitis A virus (HAV) research. The new kits offer researchers excellent accuracy, sensitivity, and convenience in studying and analyzing HAV samples. Hepatitis A is a highly contagious viral ...
-
Creative Proteomics Introduces Methionine Cycle Analysis Service for Metabolomics Research
Creative Proteomics, a leading provider of advanced proteomics and metabolomics services, is proud to announce the launch of its innovative Methionine Cycle Analysis Service. This service represents a significant leap forward in the field of metabolomics, providing researchers with a powerful tool to unravel the complexities of metabolic pathways. Methionine, a pivotal amino acid, is central to ...
-
Revolutionizing Metabolomics: Creative Proteomics Unveils LC-MS/MS Untargeted Metabolomics Service
Creative Proteomics, a trailblazer in advanced proteomics and metabolomics services, is proud to unveil its groundbreaking LC-MS/MS Untargeted Metabolomics service. This release marks a pivotal moment in the world of metabolomics research, offering scientists a game-changing tool to explore the hidden complexities of the metabolome. Metabolomics, the systematic study of small molecules within ...
-
Multi-Type Animal Cognitive Behavioral Tests for Disease Research
In the pursuit of advancing disease research and its treatment, animal cognitive behavior is studied in a wide range of animal species. The innovative multi-type animal cognitive behavioral tests are set to complement disease research methodology, enabling scientists to gain deeper insight into the complexities of cognitive functioning and its implications in various pathological conditions. ...
By Protheragen
-
Animal Emotional Behavior Tests for Anxiety and Depression Treatment
In today’s fast-paced and stressful society, the prevalence of anxiety and depression has become a significant concern. Emotion-related animal behavior tests aim to provide a good research tool for the study of emotion-associated diseases. Anxiety and depression affect millions of individuals worldwide, leading to a significant burden on public health and impacting overall quality of ...
By Protheragen
-
Comprehensive Gene Therapy Development Solutions to Further Boost Rare Disease Research
As several gene therapy approvals for rare disease treatment gain steam in 2023, a comprehensive set of gene therapy development solutions is released to pave richer avenues for rare disease research. This path-breaking move sees the integration of cutting-edge technology with state-of-art research facilities to amplify the possibilities of devising effective remedies for rare diseases. Rare ...
By Protheragen
-
Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services
Creative Enzymes, an esteemed frontrunner in the field of enzyme-related solutions, is excited to introduce an innovative suite of screening services designed to cater to the evolving needs of today's scientific community. In the ever-changing realm of scientific research, the importance of comprehensive and dependable screening for substrates, inhibitors, and ligands has become increasingly ...
-
Flanders, Propelling to the Forefront of the Bio-Based Transformation
The Singapore Week of Innovation and Technology (SWITCH) brings together leaders, entrepreneurs, creators, accelerators and investors from the Global-Asia innovation ecosystem. Through the open exchange of new ideas, vibrant networks and a line-up of innovation-centric activities, SWITCH provides a global platform to catalyse meaningful collaboration between different fields and markets. ...
By Avecom NV
-
CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology
CD Genomics, a distinguished leader in genomics and sequencing services, has proudly unveiled its groundbreaking CRISPR Screen Sequencing technology. This innovative solution promises to expedite discoveries, facilitate target identification, and optimize drug development pipelines within the biotechnology and pharmaceutical industries. CRISPR Screen Sequencing, a genome-wide screening ...
By CD Genomics
-
CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights
CD Genomics, an excellent leader in genomics and bioinformatics, has unveiled a groundbreaking leap forward in TCR-Seq technology, poised to revolutionize immune repertoire profiling. With an unwavering commitment to innovation and precision, CD Genomics continues to redefine the genomics research landscape. TCR-Seq, short for T Cell Receptor Sequencing, is an instrumental tool that enables ...
By CD Genomics
-
Huateng Pharma Launches Exciting New Product Line - Fexuprazan and Vonoprazan Intermediates
Huateng Pharma, a leading innovator in pharmaceutical intermediates, is proud to announce the introduction of its latest product line - Gastrointestinal API Intermediates, featuring the groundbreaking compounds Fexuprazan and Vonoprazan Intermediates. These cutting-edge substances have been meticulously developed to meet the growing demands of the pharmaceutical industry. Fexuprazan Intermediates ...
-
Biopharma PEG: Your Premier Source for High-Purity Monodispersed PEGs
Biopharma PEG, a leading provider of innovative solutions for the pharmaceutical industry, is proud to announce an extensive inventory of monodispersed PEGs (Polyethylene Glycols) that cater to a wide range of applications, including Antibody Drug Conjugates (ADCs), PROTACs, drug delivery systems, and more. Our comprehensive collection includes mPEG36-NH2, NH2-PEG24-COOH, mPEG11-SPA, ...
-
Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics
In the ever-evolving field of pharmaceuticals, CD Formulation has emerged as a major player in developing innovative drug delivery systems aimed at enhancing the efficacy and safety of therapies. Through its expertise in various cutting-edge technologies such as microneedle and thin film technologies, transdermal patches, microencapsulation, and nanoparticle development, CD Formulation is ...
-
CELLINK Announces CELLINK Vivoink: Our First Medical-Grade Bioink
CELLINK, a global leader in bioprinting technologies, is proud to announce a pioneering innovation in the field of regenerative medicine and tissue engineering with the launch of CELLINK Vivoink, the first-ever medical-grade bioink specially designed to support researchers on their clinical translational journey. CELLINK Vivoink is optimized for superior printability, mechanical stability, and ...
By CELLINK
-
mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board
Sagaert’s CEO appointment follows his successful interim period implementing etherna’s new partnership-driven business strategy. Sagaert joined etherna in 2017 and brings extensive operational and strategic experience in the life sciences industry. Dekkers, who is the founder of investment and advisory firm Novalis Capital Partners LLC and former CEO of Bayer AG and Thermo ...
By eTheRNA
-
Protecting the Immunocompromised from Invasive Mold Infection Risks in Hospitals and Buildings throughout Puerto Rico
Anyone with a weakened or suppressed immune system could be at heightened risk of developing an invasive mold infection. The Centers for Disease Control and Prevention (CDC) warns that these types of infections can occur days to weeks after exposure to fungi that live in the environment. The agency goes so far as to advise physicians to keep invasive mold infections in mind when treating people ...
-
CELLINK and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence
CELLINK, a leading global provider of bioprinting technologies, and the University of California, San Diego (UCSD), a world-renowned research institution, are pleased to announce their partnership to establish a 3D bioprinting Centre of Excellence. This partnership aims to facilitate the utilization of advanced bioprinting technologies and promote cutting-edge research in the fields of drug ...
By CELLINK
-
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has recently announced a series of new Anti-Small Molecule Label Antibodies to facilitate the development of nucleic acid lateral flow immunoassay (NALFIA). These antibodies can specifically bind to small molecule labels and offer customers multiple choices, including Anti Digoxin monoclonal ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you